VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,625 | -65.2% | 3,802 | -9.0% | 0.02% | -63.9% |
| Q2 2023 | $102,511 | +12.8% | 4,179 | +7.0% | 0.06% | +22.0% |
| Q1 2023 | $90,869 | -33.6% | 3,905 | -27.8% | 0.05% | -29.6% |
| Q4 2022 | $136,876 | +50.4% | 5,408 | +15.2% | 0.07% | +97.2% |
| Q3 2022 | $91,000 | -23.5% | 4,695 | +0.8% | 0.04% | -18.2% |
| Q2 2022 | $119,000 | +36.8% | 4,659 | +38.1% | 0.04% | +12.8% |
| Q1 2022 | $87,000 | -41.6% | 3,374 | -5.4% | 0.04% | -30.4% |
| Q4 2021 | $149,000 | -26.6% | 3,568 | -23.5% | 0.06% | -37.1% |
| Q3 2021 | $203,000 | -12.5% | 4,664 | -5.0% | 0.09% | -6.3% |
| Q2 2021 | $232,000 | -50.8% | 4,912 | -46.7% | 0.10% | -52.3% |
| Q1 2021 | $472,000 | +95.0% | 9,214 | +1.9% | 0.20% | +99.0% |
| Q4 2020 | $242,000 | -21.7% | 9,044 | +0.5% | 0.10% | -38.3% |
| Q3 2020 | $309,000 | -26.3% | 9,001 | -12.0% | 0.16% | -18.2% |
| Q2 2020 | $419,000 | – | 10,226 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |